Anthony C. Caputa

Array ( [id] => 3768338 [patent_doc_number] => 05733778 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'A2 gene of leishmania which is differentially-expressed in amastigote form' [patent_app_type] => 1 [patent_app_number] => 8/452531 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 5822 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733778.pdf [firstpage_image] =>[orig_patent_app_number] => 452531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623126 [patent_doc_number] => 05686077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)' [patent_app_type] => 1 [patent_app_number] => 8/453554 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5928 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686077.pdf [firstpage_image] =>[orig_patent_app_number] => 453554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4019052 [patent_doc_number] => 05882651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Attenuated respiratory syncytial virus vaccine compositions' [patent_app_type] => 1 [patent_app_number] => 8/453294 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23700 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882651.pdf [firstpage_image] =>[orig_patent_app_number] => 453294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848206 [patent_doc_number] => 05766922 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Functional ligands for the axonal cell rcognition molecule contactin' [patent_app_type] => 1 [patent_app_number] => 8/452052 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 14645 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766922.pdf [firstpage_image] =>[orig_patent_app_number] => 452052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686402 [patent_doc_number] => 05695994 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules' [patent_app_type] => 1 [patent_app_number] => 8/443341 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 6725 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695994.pdf [firstpage_image] =>[orig_patent_app_number] => 443341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3663010 [patent_doc_number] => 05668013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Antigen recognized by patients with antibody associated paraneoplastic cerebellar degeneration, DNA encoding same and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/427993 [patent_app_country] => US [patent_app_date] => 1995-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6190 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668013.pdf [firstpage_image] =>[orig_patent_app_number] => 427993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3824689 [patent_doc_number] => 05783404 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Methods and compositions for determining HER-2/neu expression using monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/421356 [patent_app_country] => US [patent_app_date] => 1995-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 8641 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783404.pdf [firstpage_image] =>[orig_patent_app_number] => 421356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692091 [patent_doc_number] => 05679530 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Isolated protein having molecular weight of from about 55 kilodaltons to about 65 kilodaltons (SDS-page) which binds to prion protein' [patent_app_type] => 1 [patent_app_number] => 8/421059 [patent_app_country] => US [patent_app_date] => 1995-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2710 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679530.pdf [firstpage_image] =>[orig_patent_app_number] => 421059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3642675 [patent_doc_number] => 05637303 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Use of a phospholipase D mutant of Corynebacterium pseudotuberculosis for vaccination' [patent_app_type] => 1 [patent_app_number] => 8/416463 [patent_app_country] => US [patent_app_date] => 1995-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 4111 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637303.pdf [firstpage_image] =>[orig_patent_app_number] => 416463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217748 [patent_doc_number] => 06040148 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Corynebacterial stress proteins' [patent_app_type] => 1 [patent_app_number] => 8/409901 [patent_app_country] => US [patent_app_date] => 1995-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5180 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040148.pdf [firstpage_image] =>[orig_patent_app_number] => 409901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3630860 [patent_doc_number] => 05631010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1' [patent_app_type] => 1 [patent_app_number] => 8/403584 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9451 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631010.pdf [firstpage_image] =>[orig_patent_app_number] => 403584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4041698 [patent_doc_number] => 05874300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Campylobacter jejuni antigens and methods for their production and use' [patent_app_type] => 1 [patent_app_number] => 8/402804 [patent_app_country] => US [patent_app_date] => 1995-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14778 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874300.pdf [firstpage_image] =>[orig_patent_app_number] => 402804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659465 [patent_doc_number] => 05659012 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Peptide which binds SH.sub.2 domains of protein tyrosine phosphatase SH-PTP1' [patent_app_type] => 1 [patent_app_number] => 8/402006 [patent_app_country] => US [patent_app_date] => 1995-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9019 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/659/05659012.pdf [firstpage_image] =>[orig_patent_app_number] => 402006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3953995 [patent_doc_number] => 05935818 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/394152 [patent_app_country] => US [patent_app_date] => 1995-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 101 [patent_no_of_words] => 40038 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935818.pdf [firstpage_image] =>[orig_patent_app_number] => 394152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3925434 [patent_doc_number] => 05877017 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/389360 [patent_app_country] => US [patent_app_date] => 1995-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 7898 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877017.pdf [firstpage_image] =>[orig_patent_app_number] => 389360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729154 [patent_doc_number] => 05693497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Process for expressing the hepatitis B virus antigen using a Saccharomyces cerevisiae transformant' [patent_app_type] => 1 [patent_app_number] => 8/378011 [patent_app_country] => US [patent_app_date] => 1995-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9622 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693497.pdf [firstpage_image] =>[orig_patent_app_number] => 378011 [rel_patent_id] =>[rel_patent_doc_number] =>)